• Citer

Preoperative treatment with mFOLFIRINOX or Gemcitabine/Nab-paclitaxel +/- isotoxic high-dose stereotactic body Radiation Therapy (iHD-SBRT) for borderline resectable pancreatic adenocarcinoma (the STEREOPAC trial): study protocol for a randomised comparative multicenter phase II trial.

par Bouchart, Christelle ;Navez, Julie ;Borbath, Ivan;Geboes, Karen;Vandamme, Timon;Closset, Jean ;Moretti, Luigi ;Demetter, Pieter ;Paesmans, Marianne ;Van Laethem, Jean-Luc
Référence BMC cancer, 23, 1, page (891)
Publication Publié, 2023-09-01

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Preoperative treatment with mFOLFIRINOX or Gemcitabine/Nab-paclitaxel +/- isotoxic high-dose stereotactic body Radiation Therapy (iHD-SBRT) for borderline resectable pancreatic adenocarcinoma (the STEREOPAC trial): study protocol for a randomised comparative multicenter phase II trial.
Auteur:	Bouchart, Christelle; Navez, Julie; Borbath, Ivan; Geboes, Karen; Vandamme, Timon; Closset, Jean; Moretti, Luigi; Demetter, Pieter; Paesmans, Marianne; Van Laethem, Jean-Luc
Informations sur la publication:	BMC cancer, 23, 1, page (891)
Statut de publication:	Publié, 2023-09-01
Sujet CREF:	Sciences bio-médicales et agricoles
Mots-clés:	Borderline resectable
	Chemotherapy
	Clinical trial
	FOLFIRINOX
	Neoadjuvant therapy
	Pancreatic adenocarcinoma
	Stereotactic body radiation
MeSH keywords:	Humans
	Gemcitabine
	Adenocarcinoma -- therapy
	Antineoplastic Combined Chemotherapy Protocols -- adverse effects
	Quality of Life
	Radiosurgery -- adverse effects
	Pancreatic Neoplasms -- drug therapy -- radiotherapy
	Randomized Controlled Trials as Topic
	Multicenter Studies as Topic
	Clinical Trials, Phase II as Topic
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:1471-2407
	info:doi/10.1186/s12885-023-11327-x
	info:pii/10.1186/s12885-023-11327-x
	info:scp/85171876826
	info:pmid/37735634
	PMC10512504